Conference Coverage
Conference Coverage
HPV vaccine doesn’t provide herd immunity or crossprotection
Key clinical point: HPV types 16 and 18 have significantly decreased since the advent of the vaccine, but only among vaccinated women. Major...
Conference Coverage
Gene expression test predicts melanoma metastasis
ORLANDO – A commercially available melanoma gene expression test had a negative predictive value of 98% for metastasis, and correctly identified...
Conference Coverage
Statins, but not aspirin, linked to lower pancreatic cancer risk
Key clinical point: Statin use was linked to lower odds of pancreatic ductal adenocarcinoma, while aspirin use was not. Major finding: Statin use...
Conference Coverage
Resection of recurrence shows survival benefit for adrenocortical carcinoma
Key clinical point: Surgery carries a significant survival benefit in patients with recurrent adrenocortical carcinoma (ACC). Major finding:...
Conference Coverage
Histologic examination of anastomotic stapler doughnuts may not yield clinical benefit
A multicenter of patients who had low anterior resection with stapled anastomosis for rectal cancer found no clinical or economic benefit in...
Conference Coverage
Sponge-on-a-string could move Barrett’s screening from GI lab to primary care
SAN DIEGO – An inexpensive sponge-on-a-string esophageal biopsy, combined with methylated DNA analysis, discriminated Barrett’s esophagus from...
Conference Coverage
Colorectal cancer threatens younger people
Health care providers should be alert for symptoms of colorectal cancer in younger patients, and encourage screening if symptoms are present.
Conference Coverage
Accuracy of gene test for thyroid nodules questioned
BALTIMORE – Biopsy results from a commercially available genetic test for ruling out malignancy of thyroid nodules may not provide reliable...
Conference Coverage
Methylated DNA markers hold promise for Lynch syndrome
Methylated DNA markers (MDMs) have several advantages that are helpful for Lynch syndrome.
Conference Coverage
Novel combination delays progression of recurrent gynecologic tumors
Key clinical point: The combination of a vascular disrupter and antiangiogenic agent improved progression-free survival in epithelial cancers of...